Vigil Neuroscience, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Vigil Neuroscience's 10-K filing highlights the company's ongoing clinical trials for neurodegenerative diseases and its financial position.
Vigil Neuroscience, a clinical-stage biotech company, released its 2023 annual report, highlighting progress in its neurodegenerative disease programs and ongoing clinical trials.